
Psychemedics Corporation PMD
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
Psychemedics Corporation Langfristiger Schuldenstrom 2011-2026 | PMD
Langfristiger Schuldenstrom Jährlich Psychemedics Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.05 M | 1.04 M | 984 K | 875 K | 963 K | 416 K | 957 K | 1.14 M | 1.62 M | 1.4 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 1.62 M | 416 K | 1.04 M |
Langfristiger Schuldenstrom anderer Aktien in der Diagnostik & Forschung
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
2.18 M | - | -6.23 % | $ 30.6 M | ||
|
Aspira Women's Health
AWH
|
202 K | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
518 K | - | -13.05 % | $ 7.29 M | ||
|
DermTech
DMTK
|
3.07 M | - | -11.32 % | $ 2.94 M | ||
|
Enzo Biochem
ENZ
|
841 K | - | -8.98 % | $ 14.8 K | ||
|
Castle Biosciences
CSTL
|
1.66 M | $ 25.13 | 1.19 % | $ 698 M | ||
|
Exact Sciences Corporation
EXAS
|
33.6 M | - | - | $ 19.8 B | ||
|
Danaher Corporation
DHR
|
199 M | $ 196.66 | 2.95 % | $ 140 B | ||
|
CareDx, Inc
CDNA
|
6.52 M | $ 18.02 | 1.98 % | $ 960 M | ||
|
DexCom
DXCM
|
21.6 M | $ 65.77 | 4.21 % | $ 25.7 B | ||
|
Akumin
AKU
|
17.2 M | - | -17.87 % | $ 25.9 M | ||
|
Fulgent Genetics
FLGT
|
1.44 M | $ 16.25 | 2.14 % | $ 491 M | ||
|
Heska Corporation
HSKA
|
2.94 M | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
475 K | - | -20.0 % | $ 1.06 M | ||
|
Guardant Health
GH
|
27.7 M | $ 94.49 | 1.28 % | $ 11.8 B | ||
|
Co-Diagnostics
CODX
|
662 K | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Accelerate Diagnostics
AXDX
|
829 K | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
147 K | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
264 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
21.5 M | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
57.7 M | $ 176.18 | 3.87 % | $ 8.73 B | ||
|
Motus GI Holdings
MOTS
|
169 K | - | -34.28 % | $ 263 K | ||
|
Biodesix
BDSX
|
719 K | $ 14.28 | -1.72 % | $ 1.85 B | ||
|
ICON Public Limited Company
ICLR
|
24.3 M | $ 108.06 | 0.84 % | $ 8.91 B | ||
|
Interpace Biosciences
IDXG
|
431 K | $ 1.99 | -0.25 % | $ 8.8 M | ||
|
OpGen
OPGN
|
174 K | - | -16.95 % | $ 1.54 M | ||
|
Illumina
ILMN
|
79 M | $ 128.36 | 1.52 % | $ 20.4 B | ||
|
PerkinElmer
PKI
|
589 M | - | -0.91 % | $ 14.7 B | ||
|
IQVIA Holdings
IQV
|
93 M | $ 174.45 | 2.3 % | $ 30 B | ||
|
Quotient Limited
QTNT
|
3.45 M | - | -11.32 % | $ 1.1 M | ||
|
QIAGEN N.V.
QGEN
|
23.4 M | - | - | $ 10.6 B | ||
|
Laboratory Corporation of America Holdings
LH
|
191 M | $ 275.15 | 2.22 % | $ 22.9 B | ||
|
Anixa Biosciences
ANIX
|
41 K | $ 2.66 | -1.3 % | $ 86.3 K | ||
|
Lantheus Holdings
LNTH
|
3.8 M | $ 80.09 | 2.57 % | $ 5.41 B | ||
|
Biomerica
BMRA
|
358 K | $ 2.16 | - | $ 4.96 M | ||
|
BioNano Genomics
BNGO
|
697 K | $ 1.17 | 0.02 % | $ 6.37 M | ||
|
Check-Cap Ltd.
CHEK
|
264 K | - | - | $ 9.42 M | ||
|
Medpace Holdings
MEDP
|
23.2 M | $ 523.59 | 2.96 % | $ 15.1 B | ||
|
Mettler-Toledo International
MTD
|
35.1 M | $ 1 323.64 | 4.22 % | $ 27.3 B | ||
|
Myriad Genetics
MYGN
|
6.9 M | $ 4.86 | 2.43 % | $ 450 M | ||
|
Celcuity
CELC
|
54 K | $ 116.44 | 0.76 % | $ 5.44 B | ||
|
NeoGenomics
NEO
|
4.78 M | $ 8.3 | 2.98 % | $ 1.06 B | ||
|
Neogen Corporation
NEOG
|
5.64 M | $ 10.53 | 5.46 % | $ 2.28 B | ||
|
Natera
NTRA
|
7.64 M | $ 211.61 | 1.12 % | $ 20.8 B | ||
|
National Research Corporation
NRC
|
451 K | $ 17.63 | 3.43 % | $ 395 M |